Latest filing published 31 Jan 2023 for Meridian Bioscience INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
John McCune Rice Jr.: trading record in brief
John McCune Rice Jr. (board member) discloses dealings in Meridian Bioscience Inc to SEC (Form 4). We count 14 filings; the first trade dates from 7 February 2018 and the latest from 31 January 2023.
In open-market terms, that means 3 purchases worth €53k on one side and 1 sale worth €385k on the other. The net balance comes to €332k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 4 share grants and 3 option exercises.
In size, the median ticket on the buying side is €20k. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 31 January 2023, the filings show a transaction in Meridian Bioscience Inc. The last insider purchase was made public on 26 February 2020, 2,447 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John McCune Rice Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 27,449 sharesCommon StockSEC:0001567619-23-001535:0
- 3,012 shares0Common StockSEC:0001127602-22-002350:0
2 of 2 declarations